I don't agree with the NPAT projections above - the lowest NPAT in the past three years was $7.5m in FY19 and that was with an EBITDA of $11.6m, slightly higher than the $11.1m EBITDA for 1HY21 alone. Surely the doubling of this number for the full year should elevate NPAT to above $8m if not higher (FY20 NPAT was $9m on $15m EBITDA). All the share based payments, deferred considerations and earnout payments might muddy the water a bit but it is clear that growth has been great after FY20 with the acquisitions.
I don't agree with the NPAT projections above - the lowest NPAT...
Add ACF (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.12 |
Change
-0.010(0.88%) |
Mkt cap ! $329.2M | |||
| Open | High | Low | Value | Volume |
| $1.14 | $1.14 | $1.12 | $576.5K | 513.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 7936 | $1.12 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.13 | 11858 | 1 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.12 |
Change
-0.010 ( 1.27 %) |
||||
| Open | High | Low | Volume | ||
| $1.13 | $1.13 | $1.12 | 32183 | ||
| Last updated 15.59pm 03/05/2024 ? | |||||
| ACF (ASX) Chart |